Athira's Alzheimer's Drug Passes Futility Analysis; Data Targeted For 2024

 
• By Jessica Merrill
  
car veering
Athira thinks its Alzheimer's drugs is back on the development road • Source: Shutterstock

More from Clinical Trials

More from R&D